Dergiler / Diagnostic and Interventional Radiology / 2015 / Cilt: 21 - Sayı: 5

Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences

Sayfa
368–375
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Our results support the inclusion of DWI in the initial MRI protocol for the detection of cervical cancer recurrence, leaving DCE sequences as an option for uncertain cases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE We aimed to evaluate the added value of diffusion-weighted imaging (DWI) to standard magnetic resonance imaging (MRI) for detecting post-treatment cervical cancer recurrence.
📊
Temel Bulgular & Veri:The detection accuracy of T2-weighted (T2W) images was compared with that of T2W MRI combined with either dynamic contrast-enhanced (DCE) MRI or DWI.METHODSThirty-eight women with clinically suspected uterine cervical cancer recurrence more than six months after treatment completion were examined with 1.5 Tesla MRI including T2W, DCE, and DWI sequences.
💡
Sonuç & Katkı:Our results support the inclusion of DWI in the initial MRI protocol for the detection of cervical cancer recurrence, leaving DCE sequences as an option for uncertain cases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

PURPOSE We aimed to evaluate the added value of diffusion-weighted imaging (DWI) to standard magnetic resonance imaging (MRI) for detecting post-treatment cervical cancer recurrence. The detection accuracy of T2-weighted (T2W) images was compared with that of T2W MRI combined with either dynamic contrast-enhanced (DCE) MRI or DWI.METHODSThirty-eight women with clinically suspected uterine cervical cancer recurrence more than six months after treatment completion were examined with 1.5 Tesla MRI including T2W, DCE, and DWI sequences. Disease was confirmed histologically and correlated with MRI findings. The diag-nostic performance of T2W imaging and its combination with either DCE or DWI were analyzed. Sensitivity, positive predictive value, and accuracy were calculated.RESULTSThirty-six women had histologically proven recurrence. The accuracy for recurrence detection was 80% with T2W/DCE MRI and 92.1% with T2W/DWI. The addition of DCE sequences did not signifi-cantly improve the diagnostic ability of T2W imaging, and this sequence combination misclassified two patients as falsely positive and seven as falsely negative. The T2W/DWI combination revealed a positive predictive value of 100% and only three false negatives.CONCLUSIONThe addition of DWI to T2W sequences considerably improved the diagnostic ability of MRI. Our results support the inclusion of DWI in the initial MRI protocol for the detection of cervical cancer recurrence, leaving DCE sequences as an option for uncertain cases.

🔖

Bu Makaleye Atıf Yap

LUCAS, R., DİAS, J. L., CUNHA, T. M. (2015). Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences. Diagnostic and Interventional Radiology, Cilt: 21 - Sayı: 5, 368–375. https://ajindex.com/articles/208406

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOB- OCAN 2012 v 1.0, Cancer incidence and mortal- ity worldwide: IARC cancer base no. 11: Inter- national Agency for Research on Cancer. Lyon, France, 2013. Available at: http://globocan.iarc. fr. Accessed on June 8, 2014. Long HJ. Management of metastatic cervical cancer: review of the literature. J Clin Oncol 2007; 10:2966-2974. [CrossRef] Liyanage SH, Roberts CA, Rockall AG. MRI and PET scans for primary staging and detection of cervical cancer recurrence. Womens Health (Lond Engl) 2010; 6:251-267. [CrossRef] Schieda N, Malone SC, Dandan OA, Ram- chandani P, Siegelman ES. Multi-modality organ-based approach to expected imaging findings, complications and recurrent tumour in the genitourinary tract after radiotherapy. Insights Imaging 2014; 5:25-40. [CrossRef] Gadducci A, Tana R, Cosio S, Cionini L. Treat- ment options in recurrent cervical cancer (Re- view). Oncol Lett 2010; 1:3-11.
  2. Fulcher AS, O'Sullivan SG, Segreti EM, Kavana- gh BD. Recurrent cervical carcinoma: typical and atypical manifestations. Radiographics 1999; 19:103-116. [CrossRef] Salani R, Backes FJ, Fung MF, et al. Posttreatment surveillance and diagnosis of recurrence in wom- en with gynecologic malignancies: Society of Gy- necologic Oncologists recommendations. Am J Obstet Gynecol 2011; 204:466-478. [CrossRef] Koh WJ, Greer BE, Abu-Rustum NR, et al. Cer- vical cancer. J Natl Compr Canc Netw 2013; 11:320-343.
  3. Togashi K, Nishimura K, Sagoh T, et al. Carci- noma of the cervix: staging with MR imaging. Radiology 1989; 171:245-251. [CrossRef] Kinkel K, Ariche M, Tardivon AA, et al. Differen- tiation between recurrent tumor and benign conditions after treatment of gynecologic pel- vic carcinoma: value of dynamic contrast-en- hanced subtraction MR imaging. Radiology 1997; 204:55-63. [CrossRef] Antunes D, Cunha TM. Recurrent cervical can- cer: how can radiology be helpful. OMICS J Ra- diology 2013; 2:138. Hricak H, Swift PS, Campos Z, Quivey JM, Gilden- gorin V, Göranson H. Irradiation of the cervix uteri: value of unenhanced and contrast-enhanced MR imaging. Radiology 1993; 189:381-388. [CrossRef] Hawighorst H, Knapstein PG, Schaeffer U, et al. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recur- rent tumors from benign conditions. AJR Am J Roentgenol 1996; 166:401-408. [CrossRef] Nougaret S, Tirumani SH, Addley H, Pand- ey, H, Sala E, Reinhold C. Pearls and pi